Skip to main content
S 2720 117th Congress Senate Armed Forces and National Security Cancer Congressional oversight Government information and archives Health care quality Health information and medical records Medical research Medical tests and diagnostic methods Veterans' medical care

Veterans’ Prostate Cancer Treatment and Research Act

Introduced: September 13, 2021 Introduced by: Moran, Jerry Republican · Kansas See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 15, 2021
Committee on Veterans' Affairs. Ordered to be reported without amendment favorably.
Oct 20, 2021
Committee on Veterans' Affairs. Hearings held.
Sep 13, 2021
Read twice and referred to the Committee on Veterans' Affairs.
Sep 13, 2021
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Veterans' Prostate Cancer Treatment and Research Act

This bill requires the Department of Veterans Affairs (VA) to establish in its National Surgery Office an interdisciplinary clinical pathway for all stages of prostate cancer. Clinical pathways are health care management tools designed around research and evidence-based practices that provide direction for the care and treatment of a specific condition. The clinical pathway must include specified elements, such as a diagnosis pathway and a treatment pathway.

The VA must consult with and incorporate feedback from (1) veterans who have received prostate cancer care at its medical facilities, and (2) experts in multidisciplinary cancer care and clinical research.

Additionally, the VA must publish the clinical pathway on a public VA website and annually update the pathway as needed based on medical literature and evidence-based guidelines.

The bill also requires the VA to submit a plan to establish a prostate cancer program using the comprehensive prostate cancer clinical pathway.

What's happening now December 15, 2021

Committee on Veterans' Affairs. Ordered to be reported without amendment favorably.

 Related & companion bills 1
  • HR 4880 Identical bill Veterans’ Prostate Cancer Treatment and Research Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 5
All 5 Democratic 3 Republican 2
D
Peters, Gary C.
Michigan · Aug 4, 2022
 R
Boozman, John
Arkansas · Jan 10, 2022
 D
Coons, Christopher A.
Delaware · Jan 10, 2022
 R
Blackburn, Marsha
Tennessee · Dec 7, 2021
 D
Blumenthal, Richard
Connecticut · Dec 2, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). S. 2720: Veterans’ Prostate Cancer Treatment and Research Act. 117th Congress. Open America. https://openamerica.io/bill/117-S-2720/
MLA
"S. 2720: Veterans’ Prostate Cancer Treatment and Research Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-2720/.
Bluebook (legal)
S. 2720, 117th Cong. (2026), https://openamerica.io/bill/117-S-2720/.
Markdown link
[S. 2720: Veterans’ Prostate Cancer Treatment and Research Act](https://openamerica.io/bill/117-S-2720/)
Report a problem